Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer
Crossref DOI link: https://doi.org/10.1007/s11864-024-01252-x
Published Online: 2024-08-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bischoff, Hervé http://orcid.org/0000-0003-3382-9635
Espié, Marc
Petit, Thierry
Text and Data Mining valid from 2024-08-17
Version of Record valid from 2024-08-17
Article History
Accepted: 25 July 2024
First Online: 17 August 2024
Declarations
:
: The authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.